A collaborative analysis of individual participant data from 19 prospective studies assesses circulating vitamin D and prostate cancer risk

Previous prospective studies assessing the relationship between circulating concentrations of vitamin D and prostate cancer risk have shown inconclusive results, particularly for risk of aggressive disease. In this study, we examine the association between pre-diagnostic concentrations of 25-hydroxy...

ver descrição completa

Detalhes bibliográficos
Principais autores: Travis, R, Perez-Cornago, A, Appleby, P, Hamdy, F, Key, T, Allen, N
Formato: Journal article
Publicado em: American Association for Cancer Research 2018
_version_ 1826281685564522496
author Travis, R
Perez-Cornago, A
Appleby, P
Hamdy, F
Key, T
Allen, N
author_facet Travis, R
Perez-Cornago, A
Appleby, P
Hamdy, F
Key, T
Allen, N
author_sort Travis, R
collection OXFORD
description Previous prospective studies assessing the relationship between circulating concentrations of vitamin D and prostate cancer risk have shown inconclusive results, particularly for risk of aggressive disease. In this study, we examine the association between pre-diagnostic concentrations of 25-hydroxyvitamin D (25(OH)D) and 1,25(OH)2D and the risk of prostate cancer overall and by tumor characteristics. Principal investigators of 19 prospective studies provided individual participant data on circulating 25(OH)D and 1,25(OH)2D for up to 13,462 men with incident prostate cancer and 20,261 control participants. Odds ratios (OR) for prostate cancer by study-specific fifths of season-standardized vitamin D concentration were estimated using multivariable-adjusted conditional logistic regression. 25(OH)D concentration was positively associated with risk for total prostate cancer (multivariable-adjusted OR comparing highest versus lowest study-specific fifth was 1.22, 95% CI 1.13-1.31; P trend<0.001). However, this association varied by disease aggressiveness (Pheterogeneity=0.014); higher circulating 25(OH)D was associated with a higher risk of non-aggressive disease (OR per 80 percentile increase=1.24, 1.13-1.36) but not with aggressive disease (defined as stage 4, metastases, or prostate cancer death, 0.95, 0.78-1.15). 1,25(OH)2D concentration was not associated with risk for prostate cancer overall or by tumor characteristics. The absence of an association of vitamin D with aggressive disease does not support the hypothesis that vitamin D deficiency increases prostate cancer risk. Rather, the association of high circulating 25(OH)D concentration with a higher risk of non-aggressive prostate cancer may be influenced by detection bias.
first_indexed 2024-03-07T00:32:31Z
format Journal article
id oxford-uuid:8050ac3a-949e-48db-abc9-7ecf5bc82439
institution University of Oxford
last_indexed 2024-03-07T00:32:31Z
publishDate 2018
publisher American Association for Cancer Research
record_format dspace
spelling oxford-uuid:8050ac3a-949e-48db-abc9-7ecf5bc824392022-03-26T21:22:27ZA collaborative analysis of individual participant data from 19 prospective studies assesses circulating vitamin D and prostate cancer riskJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:8050ac3a-949e-48db-abc9-7ecf5bc82439Symplectic Elements at OxfordAmerican Association for Cancer Research2018Travis, RPerez-Cornago, AAppleby, PHamdy, FKey, TAllen, NPrevious prospective studies assessing the relationship between circulating concentrations of vitamin D and prostate cancer risk have shown inconclusive results, particularly for risk of aggressive disease. In this study, we examine the association between pre-diagnostic concentrations of 25-hydroxyvitamin D (25(OH)D) and 1,25(OH)2D and the risk of prostate cancer overall and by tumor characteristics. Principal investigators of 19 prospective studies provided individual participant data on circulating 25(OH)D and 1,25(OH)2D for up to 13,462 men with incident prostate cancer and 20,261 control participants. Odds ratios (OR) for prostate cancer by study-specific fifths of season-standardized vitamin D concentration were estimated using multivariable-adjusted conditional logistic regression. 25(OH)D concentration was positively associated with risk for total prostate cancer (multivariable-adjusted OR comparing highest versus lowest study-specific fifth was 1.22, 95% CI 1.13-1.31; P trend<0.001). However, this association varied by disease aggressiveness (Pheterogeneity=0.014); higher circulating 25(OH)D was associated with a higher risk of non-aggressive disease (OR per 80 percentile increase=1.24, 1.13-1.36) but not with aggressive disease (defined as stage 4, metastases, or prostate cancer death, 0.95, 0.78-1.15). 1,25(OH)2D concentration was not associated with risk for prostate cancer overall or by tumor characteristics. The absence of an association of vitamin D with aggressive disease does not support the hypothesis that vitamin D deficiency increases prostate cancer risk. Rather, the association of high circulating 25(OH)D concentration with a higher risk of non-aggressive prostate cancer may be influenced by detection bias.
spellingShingle Travis, R
Perez-Cornago, A
Appleby, P
Hamdy, F
Key, T
Allen, N
A collaborative analysis of individual participant data from 19 prospective studies assesses circulating vitamin D and prostate cancer risk
title A collaborative analysis of individual participant data from 19 prospective studies assesses circulating vitamin D and prostate cancer risk
title_full A collaborative analysis of individual participant data from 19 prospective studies assesses circulating vitamin D and prostate cancer risk
title_fullStr A collaborative analysis of individual participant data from 19 prospective studies assesses circulating vitamin D and prostate cancer risk
title_full_unstemmed A collaborative analysis of individual participant data from 19 prospective studies assesses circulating vitamin D and prostate cancer risk
title_short A collaborative analysis of individual participant data from 19 prospective studies assesses circulating vitamin D and prostate cancer risk
title_sort collaborative analysis of individual participant data from 19 prospective studies assesses circulating vitamin d and prostate cancer risk
work_keys_str_mv AT travisr acollaborativeanalysisofindividualparticipantdatafrom19prospectivestudiesassessescirculatingvitamindandprostatecancerrisk
AT perezcornagoa acollaborativeanalysisofindividualparticipantdatafrom19prospectivestudiesassessescirculatingvitamindandprostatecancerrisk
AT applebyp acollaborativeanalysisofindividualparticipantdatafrom19prospectivestudiesassessescirculatingvitamindandprostatecancerrisk
AT hamdyf acollaborativeanalysisofindividualparticipantdatafrom19prospectivestudiesassessescirculatingvitamindandprostatecancerrisk
AT keyt acollaborativeanalysisofindividualparticipantdatafrom19prospectivestudiesassessescirculatingvitamindandprostatecancerrisk
AT allenn acollaborativeanalysisofindividualparticipantdatafrom19prospectivestudiesassessescirculatingvitamindandprostatecancerrisk
AT travisr collaborativeanalysisofindividualparticipantdatafrom19prospectivestudiesassessescirculatingvitamindandprostatecancerrisk
AT perezcornagoa collaborativeanalysisofindividualparticipantdatafrom19prospectivestudiesassessescirculatingvitamindandprostatecancerrisk
AT applebyp collaborativeanalysisofindividualparticipantdatafrom19prospectivestudiesassessescirculatingvitamindandprostatecancerrisk
AT hamdyf collaborativeanalysisofindividualparticipantdatafrom19prospectivestudiesassessescirculatingvitamindandprostatecancerrisk
AT keyt collaborativeanalysisofindividualparticipantdatafrom19prospectivestudiesassessescirculatingvitamindandprostatecancerrisk
AT allenn collaborativeanalysisofindividualparticipantdatafrom19prospectivestudiesassessescirculatingvitamindandprostatecancerrisk